Praxis Precision Medicines, Inc. (PRAX) vs Spyre Therapeutics, Inc. (SYRE)
- Praxis Precision Medicines, Inc. PRAX 241.76 −2.61%
- Spyre Therapeutics, Inc. SYRE 79.90 −0.25%
Praxis Precision Medicines, Inc. and Spyre Therapeutics, Inc. are both Biotechnology companies. Praxis Precision Medicines, Inc. and Spyre Therapeutics, Inc. are of similar size ($7.4B and $6.9B). Praxis Precision Medicines, Inc. grew revenue faster over the last twelve months: 249.5% against −81.8%. Across the 12 metrics below, Spyre Therapeutics, Inc. leads on 7 and Praxis Precision Medicines, Inc. on 5.
Valuation
Profitability
| Metric | PRAX | SYRE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (38.86%) | (28.52%) | (56.36%) |
| Return on assets | (36.80%) | (20.90%) | (48.04%) |
| Return on invested capital | (40.58%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack